Umbilical cord blood–derived platelet-rich plasma: a clinically acceptable substitute for fetal bovine serum?

Reflections
Published
Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine
Umbilical cord blood–derived platelet-rich plasma: a clinically acceptable substitute for fetal bovine serum?
Like

Related Content

Fertility and Sterility
Fertility and Sterility Fertility and Sterility

Umbilical cord blood–derived platelet-rich plasma: a clinically acceptable substitute for fetal bovine serum?

Platelet-rich plasma (PRP) is derived from blood and constitutes a plasma fraction with a concentration of platelets 3–5 times higher than in blood. On activation, platelets release a multitude of growth factors in high concentrations, including members of the transforming growth factor β superfamil…

VOLUME 115, ISSUE 2, P336-337

Authors:

Cristina Subiran, M.Sc., Stine Gry Kristensen, Ph.D., Claus Yding Andersen, D.M.Sc.

Abstract:

Reflections on "Comparison of different sources of platelet-rich plasma as treatment option for infertility-causing endometrial pathologies" by de Miguel-Gómez et al.

Read the full text here. 

Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. 

Recommended Content